Dr. Renu Swarup

@RenuSwarup

Secretary, Department of Biotechnology,Govt of India, Tweeting in my personal capacity.

Дата приєднання: червень 2018

Твіти

Ви заблокували @RenuSwarup

Ви впевнені, що хочете переглянути ці твіти? Перегляд твітів не розблокує профіль @RenuSwarup

  1. ретвітнув(ла)
    21 годину тому

    Congratulations -JNIMS testing laboratory for receiving ’s permission to start testing of COVID-19 samples.

    , , і ще 5
    Скасувати
  2. ретвітнув(ла)
    28 лип.

    A -free future can be accomplished with a united effort. We at are committed to working together to eliminate viral hepatitis as a public health threat.

    Скасувати
  3. ретвітнув(ла)
    28 лип.

    An India UK Round Table meeting on Cold Chain Technologies, with special reference to was held on 28 July 2020. Meeting was chaired by Lord Tariq Ahmed, UK Minister of State for South Asia.

    , , і ще 7
    Показати цей потік
    Скасувати
  4. ретвітнув(ла)
    27 лип.

    . supported efficacy trial with recombinant BCG vaccine for completed enrolment of about 6000 health-workers and high-risk individual’s in two months.

    , , і ще 3
    Скасувати
  5. ретвітнув(ла)
    28 лип.

    Five sites readied across four states for large scale human vaccine trials, six more in the works to ensure availability of healthy participants and "world class" facilities. Dr elaborates on the details and why it's important:

    Скасувати
  6. ретвітнув(ла)
    28 лип.

    Prof , , Prof , Secretary ; , Secretary , CEO, participated in the round table discussion. India-UK joint collaboration in this area was agreed.

    , , і ще 3
    Показати цей потік
    Скасувати
  7. ретвітнув(ла)
    20 годин тому

    Dr Raj Paroda becomes the first Indian scientist to win “MSS Award for Environment Protection”

    Скасувати
  8. ретвітнув(ла)
    27 лип.

    & are organising a Free Webinar on *Opportunities for Biotech Startups, Entrepreneurs & Incubators* in association with Ahmedabad. 🗓️29 Jul, 2020 ⏲️3:00pm-4:00pm Registration is mandatory -

    Скасувати
  9. ретвітнув(ла)
    27 лип.

    : poised for efficacy trials with recombinant BCG vaccine for funded by of . 6000 subjects enrolled across 40 hospitals in India.

    Скасувати
  10. ретвітнув(ла)
    27 лип.

    has fast-tracked development of diagnostics, vaccines, drugs, PPEs, support to startups, scaling up of diagnostic capacity & rapid regulatory response for mitigation of .

    , , і ще 4
    Скасувати
  11. ретвітнув(ла)
    27 лип.

    Biotech Interventions are focussed on a self reliant India. The E-Book can be accessed here:

    , , і ще 2
    Скасувати
  12. ретвітнув(ла)
    27 лип.

    is committed and contributing to National Missions & providing Biotech solutions which impacts society. This E-Book highlights the last one year achievements.

    , , і ще 3
    Скасувати
  13. ретвітнув(ла)
    26 лип.

    . has extended support to IPGME&R and SSKM Hospital, Kolkata for expediting the diagnostics in the state.

    , , і ще 2
    Скасувати
  14. ретвітнув(ла)
    25 лип.
    , , і ще 6
    Показати цей потік
    Скасувати
  15. ретвітнув(ла)
    25 лип.

    India-European Union Agreement on Scientific and Technological Cooperation renewed for next five years (2020-2025) This will expand the cooperation in scientific and technological research and strengthen the conduct of cooperative activities Details:

    Скасувати
  16. ретвітнув(ла)
    25 лип.

    : MD, Hasmukh Rawal, says “We are very thankful to for hand holding us when no one believed us. With the funds we were able to accelerate our process of the production”.

    Скасувати
  17. ретвітнув(ла)
    25 лип.
    , , і ще 4
    Скасувати
  18. ретвітнув(ла)
    25 лип.

    Pune-based has scaled up its production and development of -19 pathodetect testing kit with the help of strategic funding under of

    Скасувати
  19. ретвітнув(ла)
    18 лип.

    "India has about 30 vaccine candidates for , about 5 of which are on the advanced stage, and 2 of them (Bharat Biotech and Zydus-Cadilla) are on the trial stage," reveals in an interview to

    Скасувати
  20. ретвітнув(ла)
    25 лип.

    . has notified a set of Rapid Response Regulatory Frameworks to accelerate research and development pertaining to .

    , , і ще 2
    Скасувати

Схоже, завантаження займе трохи часу.

Можливо, Твіттер перенавантажено або виникли тимчасові труднощі. Спробуйте ще раз або дізнайтеся більше про стан Твіттера.

    Вам також може сподобатись

    ·